S&P 500

5.564,41

1,08%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Healthwell Acquisition Corporation I (HWEL)
Healthwell Acquisition Corporation I (HWEL) Notícias

HWEL

Healthwell Acquisition C... (HWEL)

Healthwell Acquisition Corporation I

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:HWEL

Data	Hora	Fonte	Título	Código	Companhia
17/11/2023	23:29	Business Wire	Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate	NASDAQ:HWEL	Healthwell Acquisition Corporation I
03/11/2023	20:00	Business Wire	Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.	NASDAQ:HWEL	Healthwell Acquisition Corporation I
24/10/2023	00:55	Business Wire	Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions	NASDAQ:HWEL	Healthwell Acquisition Corporation I
17/10/2023	07:00	Business Wire	Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions	NASDAQ:HWEL	Healthwell Acquisition Corporation I
04/10/2023	09:00	Business Wire	Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma	NASDAQ:HWEL	Healthwell Acquisition Corporation I
13/09/2023	17:05	Business Wire	Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple Myeloma	NASDAQ:HWEL	Healthwell Acquisition Corporation I
10/07/2023	08:00	Business Wire	Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma	NASDAQ:HWEL	Healthwell Acquisition Corporation I
23/06/2023	18:20	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:HWEL	Healthwell Acquisition Corporation I
13/06/2023	11:29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HWEL	Healthwell Acquisition Corporation I
13/06/2023	11:28	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:HWEL	Healthwell Acquisition Corporation I
12/06/2023	17:30	Business Wire	Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma	NASDAQ:HWEL	Healthwell Acquisition Corporation I
07/06/2023	11:52	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:HWEL	Healthwell Acquisition Corporation I
06/06/2023	09:00	Business Wire	Starton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare Conference	NASDAQ:HWEL	Healthwell Acquisition Corporation I
18/05/2023	18:10	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:HWEL	Healthwell Acquisition Corporation I
15/05/2023	17:21	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:HWEL	Healthwell Acquisition Corporation I
27/04/2023	08:00	Business Wire	Starton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer Treatments	NASDAQ:HWEL	Healthwell Acquisition Corporation I
14/02/2023	19:42	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:HWEL	Healthwell Acquisition Corporation I
10/02/2023	19:02	Edgar (US Regulatory)		NASDAQ:HWEL	Healthwell Acquisition Corporation I
28/03/2022	18:23	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:HWEL	Healthwell Acquisition Corporation I
22/11/2021	08:02	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:HWEL	Healthwell Acquisition Corporation I